EGFR and non-small cell lung carcinoma: Consistent with these caveats, the European Society for Medical Oncology guidelines for EGFR testing in oncogene-addicted NSCLC specifically exclude LSCC, unless unusual clinico-pathologic factors suggest otherwise (50).